Association between optic nerve head morphology in open-angle glaucoma and corneal biomechanical parameters measured with Corvis ST.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 26 07 2019
accepted: 13 12 2019
revised: 11 12 2019
pubmed: 23 12 2019
medline: 31 12 2020
entrez: 23 12 2019
Statut: ppublish

Résumé

To investigate associations between Corvis ST-measured corneal biomechanical parameters and glaucomatous optic nerve head (ONH) morphology. In total, 118 eyes of 70 patients with open-angle glaucoma were examined in this retrospective cross-sectional study. We measured Heidelberg retina tomograph and Corvis ST values in all eyes. We used the linear mixed model in four sectors (temporal superior, TS; temporal inferior, TI; nasal superior, NS; and nasal inferior, NI) to detect associations between six ONH-related parameters and 14 Corvis ST-related parameters, controlling for age, intraocular pressure, axial length, and central corneal thickness. We calculated the ONH temporal and nasal sector vertical asymmetries (TS-TI and NS-NI asymmetries) and identified the optimal linear mixed models to describe them using model selection with the second-order bias corrected Akaike Information Criterion. The Corvis ST A2 velocity was negatively associated with the rim volume in the NS sector (p < 0.05). The optimal model for TS-TI asymmetry was TS-TI asymmetry = - 3.22 + 0.15 × HC time + 0.88 × HC deflection amplitude, whereas that for NS-NI asymmetry was 0.49-0.048 × axial length - 2.45 × A2 velocity. Glaucomatous ONH superior-inferior asymmetries were associated with biomechanical properties measured with Corvis ST. Eyes with superior-dominant rim volume reduction of ONH were associated with small deformations and slow recovery of the cornea.

Identifiants

pubmed: 31865467
doi: 10.1007/s00417-019-04572-z
pii: 10.1007/s00417-019-04572-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-637

Références

Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1275-9
pubmed: 15790890
Ophthalmology. 1996 Apr;103(4):640-9
pubmed: 8618765
J Ophthalmol. 2017;2017:8515742
pubmed: 28676837
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3262-8
pubmed: 18316697
Ophthalmology. 2005 Jan;112(1):3-9
pubmed: 15629813
Br J Ophthalmol. 2017 Aug;101(8):1071-1075
pubmed: 27941050
Ophthalmology. 2016 May;123(5):930-8
pubmed: 27016459
J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):204-8
pubmed: 27413503
Lancet. 2015 Apr 4;385(9975):1295-304
pubmed: 25533656
PLoS One. 2016 Aug 31;11(8):e0161742
pubmed: 27580243
Semin Neurol. 2007 Jul;27(3):221-32
pubmed: 17577864
J Glaucoma. 1999 Aug;8(4):232-7
pubmed: 10464730
Curr Opin Ophthalmol. 2003 Apr;14(2):86-90
pubmed: 12698048
Arch Ophthalmol. 2004 Jan;122(1):17-21
pubmed: 14718289
Acta Ophthalmol. 2009 Feb;87(1):4-12
pubmed: 18507728
Graefes Arch Clin Exp Ophthalmol. 1994 Mar;232(3):141-4
pubmed: 8188062
Cochrane Database Syst Rev. 2015 Nov 30;(11):CD008803
pubmed: 26618332
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1279-1287
pubmed: 29625450
PLoS One. 2018 Sep 21;13(9):e0204451
pubmed: 30240430
J Ophthalmol. 2018 Mar 21;2018:7864219
pubmed: 29750123
PLoS One. 2017 May 4;12(5):e0176380
pubmed: 28472062
Exp Eye Res. 2011 Aug;93(2):120-32
pubmed: 20849846
Ophthalmology. 1994 Jun;101(6):1044-9
pubmed: 8008345
Arq Bras Oftalmol. 2010 Jul-Aug;73(4):354-7
pubmed: 20944940
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5557-65
pubmed: 26305527
Am J Ophthalmol. 1993 May 15;115(5):592-6
pubmed: 8488910
Ophthalmology. 1995 Dec;102(12):1810-2
pubmed: 9098281
Br J Ophthalmol. 2017 Mar;101(3):290-294
pubmed: 27474156
Optom Vis Sci. 2017 Dec;94(12):1074-1080
pubmed: 29135719
Int Ophthalmol. 1989 Jan;13(1-2):25-9
pubmed: 2744951
Curr Opin Ophthalmol. 1995 Apr;6(2):36-45
pubmed: 10150856
J Neuroophthalmol. 2016 Sep;36(3):285-9
pubmed: 27389626
Sci Rep. 2018 Feb 14;8(1):2969
pubmed: 29445204
J Glaucoma. 2012 Apr-May;21(4):209-13
pubmed: 21654511
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3783-9
pubmed: 12939292
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
PLoS One. 2014 Jan 27;9(1):e86417
pubmed: 24475117
Surv Ophthalmol. 1993 Jul-Aug;38(1):1-30
pubmed: 8235993

Auteurs

Shuichiro Aoki (S)

Department of Ophthalmology, Sapporo City General Hospital, Sapporo, Japan.

Yoshiaki Kiuchi (Y)

Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan.

Kana Tokumo (K)

Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan.

Yuri Fujino (Y)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Rehabilitation, Orthopic and Visual Science, School of Allied Health Sciences, Kitasato University, Tokyo, Kanagawa, Japan.

Masato Matsuura (M)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Rehabilitation, Orthopic and Visual Science, School of Allied Health Sciences, Kitasato University, Tokyo, Kanagawa, Japan.

Hiroshi Murata (H)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Shunsuke Nakakura (S)

Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Hyogo, Japan.

Ryo Asaoka (R)

Department of Ophthalmology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. rasaoka-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH